Category Archives: patient compliance
Shrinks Like Latuda Over the Competition, Survey Finds
Psychiatrists are more likely to recommend Sunovion Pharmaceuticals’ Latuda to colleagues than Merck’s Saphris or Novartis’ Fenapt, according to a DTW Marketing Research survey.
All three drugs are atypical antipsychotics indicated for schizophrenia, and had US launches in late 2009 (Saphris), early 2010 (Fenapt) and February of this year (Latuda). Latuda, however, appears to be gaining [...]
First Chinese Product Development Partnership Targets Tuberculosis, Malaria, AIDS
A Chinese scientific foundation and a not-for-profit tuberculosis organization announced a partnership aimed at developing new medicines for underserved public health diseases.
Billed as the first Chinese product development partnership (PDP), the Global Health R&D Center of China (GHRC) hopes to discover and develop new treatments for tuberculosis (TB) and other diseases by collaborating with pharmaceutical [...]
Also posted in Biotech, Corporate Responsibility, Deals, Emerging Markets, Global, IP, Market Access, R&D, Technology Tagged Not-for-profit, Translational Sciences Leave a comment
Will Patients Ever Comply?
Everyone knows patients don’t do what they are told. Jacky Law looks at what can be done about it.
There can be few areas of research that are as extensive and as inconclusive as that which seeks to understand why patients don’t follow doctors’ orders. According to an April 2008 IMS Health analysis of the Medline [...]

CBI Conference Highlights Innovative Programs on Patient Compliance